Your browser is: WebKit 537.36. This browser is out of date so some features on this site might break. Try a different browser or update this browser. Learn more.✕
Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.